Home > News > featured news > Camelot Wins Cue Health Omnichannel Media Buying & Planning Business

MEDICAL DEVICES

Camelot Wins Cue Health Omnichannel Media Buying & Planning Business

Camelot | June 06, 2022

After a rigorous agency selection process, Camelot Strategic Marketing & Media has been chosen as media buying and planning agency for healthcare technology company Cue Health (“Cue”) as it aims to pioneer the digital transformation of healthcare, beginning with diagnostics.

The scope of Camelot’s work for Cue includes integrated media planning and buying across Cue’s growing diagnostic platform, aimed at providing better patient outcomes by delivering on the promise of timely, informed, and connected healthcare.

“There is no question that Cue Health is on the leading edge of healthcare technology. We’re thrilled to align our passion for innovation, deep data and analytics, and creative digital media and marketing strategy to help drive their success into the future.”

Sam Bloom, CEO of Camelot Strategic Marketing & Media

Cue empowers people to live their healthiest lives by giving individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue launched the first FDA-authorized COVID-19 molecular test for at-home and over-the-counter use as well as professional point-of-care use. Outside the U.S., Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India's Central Drugs Standard Control Organization, and PSAR authorization from Singapore’s Health Sciences Authority.

The company is developing future care offerings across several categories, including respiratory health, sexual health, cardiac and metabolic health, women's health, men's health, and chronic disease management.

Within the health and wellness space, Camelot also works with Baylor Scott & White Health, the largest not-for-profit healthcare system in Texas and one of the largest in the U.S., and Glo, a digital health platform and app providing live and on-demand yoga, meditation, Pilates and fitness classes.

About Camelot

Celebrating 40 years in the media and marketing industry, Dallas-based Camelot Strategic Marketing & Media, is a fact-based, bottom-up, independent agency with 150 employees in cities across the U.S. – including Dallas, New York, Los Angeles and Baltimore. We partner with a select group of the world’s biggest brands – from TurboTax to Whole Foods to Michaels – to provide media-agnostic, transparent, insight-driven media and marketing strategy and execution.

Spotlight

Global Clinical Trial Landscape – Focus On Asia Pacific

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.

More featured news

Spotlight

Global Clinical Trial Landscape – Focus On Asia Pacific

Related News

HEALTH TECHNOLOGY, FUTURE OF HEALTHCARE

East Sussex and VitalHub Announce Licensing Agreement

VitalHub Corp. | January 17, 2023

On January 16, 2023, VitalHub Corp. announced its subsidiary's licensing agreement with East Sussex Healthcare NHS Trust. The subsidiary, Intouch with Health, has licensed its Patient Journey Platform to East Sussex Healthcare, extending the existing relationship between the two companies. East Sussex Healthcare NHS Trust provides acute hospital and community health services to the 525,000 residents of East Sussex and surrounding areas. Most of the Trust's services are provided by two district general hospitals, Eastbourne DGH and Conquest Hospital, which both have 24-hour emergency departments and provide care around the clock. Community teams from the Trust also offer patient care in-home and from several clinics and GP surgeries in East Sussex. East Sussex Healthcare has been a customer of VitalHub subsidiary (Jayex) since 2016, using its 'Enlighten' check-in solutions. By embracing Intouch's Patient Journey Platform, in particular its Intouch Flow Manager, Check-In, and Mobile App solutions, the Trust has chosen to strengthen and broaden its partnership with the company. These tools will help the Trust witness better patient care journeys, improve efficiency and patient satisfaction in care delivery, and enhance resource utilization and operational efficiency. The Patient Journey Platform facilitates NHS Trusts and other healthcare providers to efficiently manage entire patient workflows and enhance flow in outpatient care. The platform processes around 56% of all NHS outpatient attendances annually, handling 55 million outpatient appointments using real-time data and integrated blended pathways to optimize patient flow and assist in more effective patient care. Dan Matlow, CEO of VitalHub Corp., said, "We are pleased to see yet another existing legacy client extend and expand their relationship with VitalHub." He adds, "Our strategic approach to M&A has been predicated on the synergies of our collective product offerings, and our ability to cross-sell and promote organic growth among our install base. This contract provides further ratification of this thesis and of the market demand for our products and services. We look forward to continuing to execute against our growth strategy, offering best-in-class solutions to our customers." (Source – GlobeNewswire) About VitalHub Corp. Toronto-based VitalHub offers technology to health and human services providers, such as hospitals, regional health authorities, long-term care, home health, mental health, and community and social services. Its solutions include electronic health records (EHR), care coordination, case management, operational visibility, patient flow, and DOCit mobile applications. The company aims to optimize outcomes and simplify the patient experience through its software solutions.

DIGITAL HEALTHCARE

CipherHealth and SADA Collaborate to Improve Patient Care Via Looker

CipherHealth | January 06, 2023

CipherHealth, a leader in patient engagement technology and communication solutions, recently teamed up with SADA, an award-winning Google Cloud Partner, to use Google Cloud's Looker to collect socioeconomic data to improve patient care. With this new feature, CipherHealth aims to empower healthcare leaders by enabling them to collect large volumes of data and assist patients and medical professionals at each point of the care journey. Earlier, CipherHealth's platform gave doctors and nurses complete conversational and clinical information about each patient. It worked with SADA, a company that knows how to set up and run Google Cloud's analytics platform Looker, to add self-service analytics to the platform and make it more useful. With the help of Looker Embedded Analytics, CipherHealth has made it easier for its clients to access this data for analysis and visualization at any time during the patient's life. As a result of the partnership, CipherHealth's clients, which include 500 hospitals across the country, will now have access to patient data about social determinants of health (SDOH). Also, they can use in-built analytics to divide patient groups and send personalized messages to each of them separately. With this information, CipherHealth's clients can zero in on a specific patient and find out what kind of treatment they need, along with any special accommodations (like if they have trouble making appointments). CipherHealth is HIPAA-compliant, meaning it may safely analyze and transfer clients' protected health information (PHI) over the internet. The company believes combining SADA with Google Cloud can give its clients a new view of their patient populations. It will also allow the company to make changes to its care delivery that are good for patients. In line with this, SADA said that the integration of Looker from Google Cloud improves the patient experience for CipherHealth and its clients. About CipherHealth CipherHealth is a proven technology solutions partner dedicated to improving patient communication and care. Since 2009, the company has helped build the market for patient engagement by making innovative tools that help providers give excellent care. The range of patient engagement programs from CipherHealth sets new standards for care and provides healthcare businesses with the tools they need to have meaningful conversations with their patients.

FUTURE OF HEALTHCARE, MEDICAL DEVICES

Tandem Diabetes Care Successfully Acquires AMF Medical SA

Tandem Diabetes Care | January 24, 2023

On January 23, 2023, Tandem Diabetes Care, Inc., a company specializing in diabetes technology, announced that it had successfully finished acquiring AMF Medical SA, a Switzerland-based medical equipment manufacturer that created the Sigi Patch Pump. Sigi Patch Pump is a rechargeable, ergonomic patch pump intended to lower the strain of managing diabetes by utilizing pre-filled insulin cartridges. It is currently under development and is not available for retail purchase. John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care, said, "AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem's portfolio of differentiated offerings." He adds, "In addition to this innovative technology, the talented AMF team joining our Tandem family shares our commitment to simplify diabetes management and brings decades of experience from the diabetes device, life sciences, and watch-making industries." (Source – Business Wire) For this transaction, Tandem Diabetes Care received legal counsel from Baker & McKenzie LLP and Bass, Berry & Sims PLC. AMF Medical relied on SVB Securities LLC as its sole financial advisor, while Homburger AG served as its exclusive legal advisor. About Tandem Diabetes Care Headquartered in San Diego (California), Tandem Diabetes Care, Inc. is a medical device company aiming to better the lives of people with diabetes through endless innovation and a novel customer experience. The company employs a fresh and user-centric approach when it comes to developing, designing, and commercializing products for those who need to use insulin. As a result, Tandem Diabetes Care is creating a positive difference by assisting in creating better outcomes for people affected by diabetes and their healthcare providers.